首页> 美国卫生研究院文献>Pediatric Health Medicine and Therapeutics >Treating pediatric atopic dermatitis: current perspectives
【2h】

Treating pediatric atopic dermatitis: current perspectives

机译:小儿特应性皮炎的治疗:当前观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atopic dermatitis (AD) is a chronic, inflammatory skin condition which affects millions of people worldwide. It is most commonly seen in children but may also progress into adulthood. Management of this complex disease requires a multi-pronged approach which can address the myriad of issues which underscore its development. Avoidance of triggering factors is imperative in establishing consistent control of skin irritation while daily moisturization can be very effective in skin barrier repair and maintenance. Judicious use of anti-inflammatory medications has been shown to make a significant impact on both treatment as well as prevention of disease. Unfortunately, pruritus, a key feature of AD, has proven much harder to control. Finally, awareness of the risks of colonization and infection in patients with AD should be incorporated into their surveillance and management plans. While our understanding has progressed greatly regarding this disease, further research is still needed regarding future directions for both treatment and prevention.
机译:特应性皮炎(AD)是一种慢性炎症性皮肤病,影响着全球数百万人。它最常见于儿童,但也可能发展成年。处理这种复杂疾病需要采取多管齐下的方法,该方法可以解决无数的问题,这些问题是其发展的重点。要始终如一地控制皮肤刺激,必须避免触发因素,而日常保湿对皮肤屏障的修复和维护非常有效。明智地使用抗炎药已显示出对治疗和疾病预防都有重大影响。不幸的是,瘙痒症是AD的主要特征,已被证明很难控制。最后,应将对AD患者定植和感染风险的认识纳入其监测和管理计划。尽管我们对这种疾病的理解有了很大的进步,但是关于治疗和预防的未来方向仍然需要进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号